Femasys Stock Forecast
NASDAQ: FEMYHealthcareMedical Instruments & SuppliesUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
FEMY analyst consensus
Consensus (3 analysts)
none
Avg. price target
$14.33+600.73%
- Strong buy 2
- Buy 1
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 3 Wall Street analysts covering Femasys (2026-10-09), 3 rate the stock a buy or strong buy, 0 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "none". The average 12-month price target is $14.33, with a high estimate of $23.00 and a low estimate of $10.00. The average target implies upside of 600.7% from the current price of $2.05.
The spread between the highest and lowest targets is 130.0%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for FEMY.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 2 | 67% |
| Buy | 1 | 33% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-09.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $10.00 | +389.00% |
| Average target | $14.33 | +600.73% |
| High target | $23.00 | +1024.69% |